The expanded laboratories and manufacturing facilities at Nansha are expected to come online between Q1 2022 and Q3 2022.... Jul 01
Lonza USA site would carry on the manufacturing innovations... Feb 18
Lonza’s shares rose more than 60% last year, as it expanded in drugs and prepared to unload Specialty Ingredients. ... Feb 09
The collaboration will help keep the manufacturing costs down and ensure long-term flexibility to meet future demand for years to come... Dec 23
This agreement will support the ongoing efforts by the Ministry to secure early access to a COVID-19 vaccine for the people of Israel... Dec 05
The Phase III international clinical trial will recruit a total of 5,000 people across countries in Europe and the United States to assess the ... Nov 21
This agreement comes as the UK continues its efforts to secure access to safe and effective COVID-19 vaccines... Nov 19
AdCovid is its single-dose Intranasal vaccine candidate for COVID-19... Nov 10
Lonza and AstraZeneca collaborates to handle Covid challenge... Nov 04
Phase 1 trials establishes the safety level of Moderna's vaccine candidate... Jul 16
Developers obtained a certificate from the National Medical Products Administration to launch clinical trials... Jun 24
The company's vaccine is at the forefront of the efforts in developing a treatment for the fast-spreading coronavirus... May 19
North America and Europe are expected to dominate the coronavirus diagnostics market during the forecast period. Increasing investments in R&D activities along with strong ... May 02
-Advertisements-
Friday, June 14, 2024
